US FDA’s New Monoclonal Antibody Guidance Goes Beyond ‘Roadmap’ To Reduce Animal Testing

 
• By Manas Mishra
  
FDA draft guidance states sponsors can use organ-on-a-chip technology to justify shorter studies of some monoclonal antibodies. (Shutterstock)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Approval Standards

More from United States